Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings? Stanton R. MehrRichard A. Brook Leading Article 16 January 2019 Pages: 1 - 8
Peptide-Based Therapeutics for Oncology Elizaveta FisherKirill PavlenkoGalina Ramenskaya Review Article 02 January 2019 Pages: 9 - 20
Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer Vincent ClapesVanessa RousseauPascale Olivier Original Research Article 26 November 2018 Pages: 21 - 27
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users Ryan M. CarnahanJoshua J. GagneElizabeth A. Chrischilles Original Research Article 19 January 2019 Pages: 29 - 43
Safety-Related Regulatory Actions and Risk Factors for Anticancer Drugs in Japan Hiroki NakayamaNaoki MatsumaruKatsura Tsukamoto Original Research Article 26 November 2018 Pages: 45 - 52
ITS2: An Ideal DNA Barcode for the Arid Medicinal Plant Rhazya Stricta Samia A. KhanMohamed N. BaeshenNabih A. Baeshen Original Research Article 24 January 2019 Pages: 53 - 61